About Atara Biotherapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.atarabio.com/
Frequently Asked Questions
What is the 52-week range for ATRA?
The 52-week high is $19.145 and the 52-week low is $3.92.
What is the P/E ratio for ATRA?
The P/E ratio data is currently unavailable.
What is the dividend yield for ATRA?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -315.42%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -269.42%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.46.
Analyst Recommendation Trends
Wall Street analyst consensus for ATRA over the last few months:
Latest ATRA News
Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration
THOUSAND OAKS, Calif., September 30, 2026--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today provided an update that its partner, Pierre Fabre Pharmaceuticals, Inc. (PFP), has resubmitted the tabelecleucel Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA).
Atara Biotherapeutics' Pierre Fabre Pharmaceuticals Partner Refiles Tabelecleucel Biologics License Application With FDA
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and
HQL: The Rally That Makes Growth Harder (Rating Downgrade)
HQL downgraded to Hold after big rally; 12.5% yield, NAV discount and payout risks weigh on upside.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-04 | Cherry Brian N | +104,166 | $9.6 | $999,994 |
| 2026-08-17 | Nguyen AnhCo | -5,062 | $8.0764 | $40,883 |
| 2026-07-22 | Redmile Group, LLC | -55,387 | - | - |
| 2026-07-22 | Redmile Group, LLC | -38,735 | - | - |
| 2026-07-22 | Redmile Group, LLC | -101,089 | - | - |
| 2026-07-22 | Redmile Group, LLC | -60 | - | - |
| 2026-07-22 | Redmile Group, LLC | +195,211 | - | - |
| 2026-06-11 | Cherry Brian N | +24,000 | - | - |
| 2026-06-09 | Ciongoli Gregory Austin | +12,000 | - | - |
| 2026-06-09 | Fust Matthew K | +12,000 | - | - |
| 2026-06-09 | HEIDEN WILLIAM K | +12,000 | - | - |
| 2026-05-18 | Nguyen AnhCo | -5,241 | $9.1289 | $47,845 |
| 2026-05-18 | Grant-Huerta Yanina | -2,414 | $9.1286 | $22,036 |
| 2026-05-07 | EcoR1 Capital, LLC | +507,407 | $9.35 | $4,744,255 |
| 2026-05-07 | Huang James | -313,446 | $10.0975 | $3,165,021 |
| 2026-03-17 | Huang James | -259,163 | $6.6099 | $1,713,042 |
| 2026-03-17 | Huang James | -5 | $5.23 | $26 |
| 2026-03-17 | Huang James | +259,163 | $0.0001 | $26 |
| 2026-03-09 | Nguyen AnhCo | +81,100 | - | - |
| 2026-03-09 | Grant-Huerta Yanina | +20,300 | - | - |
| 2026-03-02 | Grant-Huerta Yanina | -100 | $5.083 | $508 |
| 2026-03-02 | Grant-Huerta Yanina | -377 | $5.082 | $1,916 |
| 2026-03-02 | Grant-Huerta Yanina | -1,603 | $5.081 | $8,145 |
| 2026-03-02 | Grant-Huerta Yanina | -24 | $5.077 | $122 |
| 2026-03-02 | Nguyen AnhCo | -1,442 | $5.087 | $7,335 |
| 2026-03-02 | Nguyen AnhCo | -1,298 | $5.086 | $6,602 |
| 2026-03-02 | Nguyen AnhCo | -58 | $5.08 | $295 |
| 2026-03-02 | Nguyen AnhCo | -198 | $5.079 | $1,006 |
| 2026-01-12 | Huang James | -80,554 | $6.0707 | $489,019 |
| 2025-11-28 | Huang James | -48,737 | $6.6099 | $322,147 |
| 2025-11-28 | Huang James | -1 | $14.03 | $14 |
| 2025-11-28 | Huang James | +48,737 | $0.0001 | $5 |
| 2025-11-17 | Nguyen AnhCo | -56 | $13.188 | $739 |
| 2025-11-17 | Nguyen AnhCo | -2,859 | $13.186 | $37,699 |
| 2025-11-17 | Grant-Huerta Yanina | -74 | $13.191 | $976 |
| 2025-11-17 | Grant-Huerta Yanina | -85 | $13.188 | $1,121 |
| 2025-11-17 | Grant-Huerta Yanina | -1,645 | $13.186 | $21,691 |